Calcineurin Is Activated in Rat Hearts With Physiological Left Ventricular Hypertrophy Induced by Voluntary Exercise Training
- 9 May 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (18) , 2134-2137
- https://doi.org/10.1161/01.cir.101.18.2134
Abstract
Background —Calcineurin may play a pivotal role in the signaling of cardiac hypertrophy; since this hypothesis was first put forward, controversial reports have been published using various experimental models. This study was designed to compare the physiological left ventricular hypertrophy (LVH) induced by voluntary exercise with LVH induced by aortic constriction and to determine whether calcineurin participates in the signaling of exercise-induced LVH. Methods and Results —Wistar rats were assigned to 1 of the following 5 groups: 10 weeks of voluntary exercise (EX), a sedentary regimen, a 1-week (AC1) or 4-week (AC4) ascending aortic constriction period, or a sham operation. EX rats ran 2.4±0.7 km/day voluntarily in specially manufactured cages; this was associated with an increase of LV diastolic dimension and stroke volume. Myocardial calcineurin activity markedly increased in EX rats (46.4±8.3 versus 18.4±0.5 pmol · min −1 · mg −1 in sedentary rats; P −1 · mg −1 in sham-operated rats; P −1 · mg −1 ). Treatment with cyclosporin A completely inhibited the development of LVH in EX rats, but it only partially attenuated the development of LVH in AC4 rats. Conclusions —Calcineurin was activated in exercise-induced physiological LVH and in the developing phase of LVH (AC1), but not in decompensated pressure-overload hypertrophy (AC4). Cyclosporin therapy for the prevention of LVH may be harmful because it does not block the development of pathological hypertrophy but rather that of favorable adaptive hypertrophy.Keywords
This publication has 12 references indexed in Scilit:
- Revisiting calcineurin and human heart failureNature Medicine, 2000
- The sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene promoter activity is decreased in response to severe left ventricular pressure-overload hypertrophy in rat hearts.Journal of Molecular and Cellular Cardiology, 1999
- Calcineurin and human heart failureNature Medicine, 1999
- Calcineurin inhibitors and cardiac hypertrophyNature Medicine, 1998
- Prevention of Cardiac Hypertrophy in Mice by Calcineurin InhibitionScience, 1998
- A Calcineurin-Dependent Transcriptional Pathway for Cardiac HypertrophyCell, 1998
- p53 Transactivation of the HIV-1 Long Terminal Repeat Is Blocked by PD 144795, a Calcineurin-Inhibitor with Anti-HIV PropertiesPublished by Elsevier ,1998
- Left ventricular geometry, pathophysiology and prognosisJournal of the American College of Cardiology, 1995
- Combined effects of hypertension and chronic running program on rat heartJournal of Applied Physiology, 1987
- Structural features of the athlete heart as defined by echocardiographyJournal of the American College of Cardiology, 1986